Royal Bank of Canada’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.4M | Buy |
|
|||||
|
2025
Q2 | $12.4M | Buy |
|
|||||
|
2025
Q1 | $84K | Sell |
|
|||||
|
2024
Q4 | $124K | Sell |
|
|||||
|
2024
Q3 | $314K | Buy |
|
|||||
|
2024
Q2 | $212K | Sell |
|
|||||
|
2024
Q1 | $632K | Buy |
|
|||||
|
2023
Q4 | $436K | Buy |
|
|||||
|
2023
Q3 | $242K | Buy |
|
|||||
|
2023
Q2 | $153K | Buy |
|
|||||
|
2023
Q1 | $60K | Sell |
|
|||||
|
2022
Q4 | $109K | Buy |
|
|||||
|
2022
Q3 | $77K | Buy |
|
|||||
|
2022
Q2 | $119K | Sell |
|
|||||
|
2022
Q1 | $180K | Sell |
|
|||||
|
2021
Q4 | $269K | Buy |
|
|||||
|
2021
Q3 | $283K | Buy |
|
|||||
|
2021
Q2 | $251K | Sell |
|
|||||
|
2021
Q1 | $421K | Sell |
|
|||||
|
2020
Q4 | $292K | Buy |
|
|||||
|
2020
Q3 | $247K | Buy |
|
|||||
|
2020
Q2 | $222K | Sell |
|
|||||
|
2020
Q1 | $191K | Sell |
|
|||||
|
2019
Q4 | $682K | Buy |
|
|||||
|
2019
Q3 | $218K | Sell |
|
|||||
|
2019
Q2 | $916K | Buy |
|
|||||
|
2019
Q1 | $1.76M | Buy |
|
|||||
|
2018
Q4 | $768K | Sell |
|
|||||
|
2018
Q3 | $1.71M | Buy |
|
|||||
|
2018
Q2 | $1.11M | Buy |
|